AcetaMide, N-[(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]-2,2,2-trifluoro-
AcetaMide, N-[(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]-2,2,2-trifluoro- Basic information
- Product Name:
- AcetaMide, N-[(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]-2,2,2-trifluoro-
- Synonyms:
-
- AcetaMide, N-[(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]-2,2,2-trifluoro-
- CAS:
- 865999-70-8
- MF:
- C20H24F3N3O3
- MW:
- 411.42
- Mol File:
- 865999-70-8.mol
More
Less
AcetaMide, N-[(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]-2,2,2-trifluoro- Chemical Properties
- Boiling point:
- 605.9±55.0 °C(Predicted)
- Density
- 1.45±0.1 g/cm3(Predicted)
- pka
- 9.95±0.46(Predicted)
More
Less
AcetaMide, N-[(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]-2,2,2-trifluoro- Usage And Synthesis
Uses
Saxagliptin N-Trifluoroacetate is an impurity of Saxagliptin (S143500), a potent and selective reversible inhibitor of dipeptidyl peptidase-4.
AcetaMide, N-[(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]-2,2,2-trifluoro-Supplier
Cato Research Chemicals Inc.
- Tel
- 020-81960175-677 18933936954
- tianwen.zhan@cato-chem.com
Nanjing Huanuo Biomedical Technology Co., Ltd
- Tel
- 18913906212
- 2885426135@qq.com
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd
- Tel
- 18924305345
- LK@zlstandards.com
China National Standard Pharmaceutical Corporation Limited
- Tel
- +8615391658522
- overseasales@yongstandards.com
More
Less
AcetaMide, N-[(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]-2,2,2-trifluoro-(865999-70-8)Related Product Information
- BOC-DL-PROLINE ETHYL ESTER
- (1R,3S,5R)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBOXAMIDE 2,2,2-TRIFLUOROACETIC ACID
- (1S,3R,5S)-2-tert-Butyl 3-ethyl 2-azabicyclo[3.1.0]hexane-2,3-dicarboxylate
- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-
- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-tricyclo[3.3.1.13,7]dec-1-ylacetyl]-, (1S,3S,5S)-
- Saxagliptin hydrochloride
- 1H-Pyrrole-1-carboxylic acid, 2-(aMinocarbonyl)-2,3-dihydro-, 1,1-diMethylethyl ester, (2S)-
- (S) - N- Boc- adamantylglycine
- (S)-1-Boc-2,3-dihydro-2-pyrrolecarboxylic acid ethyl ester
- 2-Azabicyclo[3.1.0]hexane-2,3-dicarboxylic acid, 2-(1,1-dimethylethyl) 3-ethyl ester, (1S,3S,5S)-
- N-Boc-L-trans-4,5-Methanoproline
- (2R)-1,2-Pyrrolidinedicarboxylic acid 1-tert-butyl 2-ethyl ester
- (1S,3S,5S)-2-(TERT-BUTOXYCARBONYL)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBOXYLIC ACID
- DSLXQSYLYSTVKT-ONZQNKQFSA-N
- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)-
- Saxagliptin O-β-D-glucuronide
- 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3S,5R)-
- N-Boc-L-trans-4,5-methanoproline ethyl ester